Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
750.00    19.00 (2.60%)
Bid:
749.00
Ask:
751.00
Spread: 2.00 (0.267%)
Market Cap: £2.02b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Trading Update

1 Jul 2026 07:00

RNS Number : 4659K
CMC Markets Plc
01 July 2026
Β 

01 July 2026

Β 

CMC MARKETS PLC

("CMC" the "Group" or the "Company")

Β 

Trading update and upgrade to FY2027 NOI guidance

Β 

CMC Markets PLC today provides an update on trading for FY2027.

As outlined at our FY2026 results, the Group entered the new financial year with strong momentum driven by exponential and exceptional growth in our B2B business. That momentum has continued to build and scale.

As a result, CMC now expects net operating income for FY2027 to be at least Β£550 million, materially ahead of previous guidance of Β£460 million to Β£480 million, with EBITDA guidance of Β£250 million.

FY2027 guidance for operating expenses excluding variable remuneration of approximately Β£280 million remains unchanged.

The strength of this performance reflects the scale of our B2B platforms driving operational gearing and delivering higher profit margins as income growth is delivered against a largely fixed cost base.

Our B2B platform business is well positioned to scale with several important milestones expected over the next 12 months and a continuous pipeline of new B2B opportunities.

Operational gearing and investing for growth through B2B platforms, products, technology and partnerships continue to drive profit margins higher.

The Group's next scheduled update is at the HY2027 results on 19 November 2026.

Β 

Β 

Β 

Forthcoming announcement dates:

19 November 2026 HY2027 Interim Results

Β 

Enquiries

CMC Markets Plc

David Fineberg, Head of Strategic Partnerships

Matthew Lee, Investor Relations investor.relations@cmcmarkets.com

Β 

Notes to Editors

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Company serves retail and institutional clients through regulated offices and branches in 12 countries with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade over 12,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, Singapore and the UK, access stockbroking services. More information is available atΒ http://www.cmcmarketsplc.com.

Β 

MAR disclosure statement

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTEAKKEDENKEFA
Date   Source Headline
24th Dec 20209:33 amRNSDirector/PDMR Shareholding
9th Dec 202011:44 amRNSDirector/PDMR Shareholding
1st Dec 202012:25 pmRNSDirector/PDMR Shareholding
23rd Nov 202011:58 amRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSInterim results
10th Nov 202010:06 amRNSDirector/PDMR Shareholding
26th Oct 20207:00 amRNSAppointment of Joint Corporate Broker
23rd Oct 20208:44 amRNSCMC welcomes ASIC consultation paper outcome
8th Oct 20207:00 amRNSTrading Update
6th Oct 20202:51 pmRNSDirector/PDMR Shareholding
22nd Sep 20204:45 pmRNSDirector/PDMR Shareholding
17th Sep 20204:19 pmRNSDirector/PDMR Shareholding
14th Sep 20209:15 amRNSIssue of Equity
9th Sep 20204:02 pmRNSDirector/PDMR Shareholding
9th Sep 20203:58 pmRNSHolding(s) in Company
3rd Sep 20207:00 amRNSTrading Update
2nd Sep 202010:40 amRNSCompliance with Listing Rule 9.2.6E
10th Aug 202011:34 amRNSDirector/PDMR Shareholding
30th Jul 20204:08 pmRNSRESULTS OF 2020 ANNUAL GENERAL MEETING
30th Jul 20201:58 pmRNSDirector/PDMR Shareholding
20th Jul 20202:14 pmRNSHolding(s) in Company
13th Jul 20207:00 amRNSAppointment of Chief Technology Officer
8th Jul 20203:41 pmRNSDirector/PDMR Shareholding
3rd Jul 20207:00 amRNSQ1 2021 Trading Update
11th Jun 20207:00 amRNSFinal results
8th Jun 20202:59 pmRNSDirector/PDMR Shareholding
7th May 20204:44 pmRNSDirector/PDMR Shareholding
8th Apr 20208:35 amRNSDirector/PDMR Shareholding
3rd Apr 20207:00 amRNSFY 2020 Pre-Close Trading Update
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSCOVID-19 and Trading Update
12th Mar 20204:37 pmRNSPrice Monitoring Extension
9th Mar 20202:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSTrading Update
7th Feb 202010:56 amRNSDirector/PDMR Shareholding
23rd Jan 20207:00 amRNSQ3 Trading Update
8th Jan 20203:20 pmRNSDirector/PDMR Shareholding
9th Dec 20192:29 pmRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSInterim Results
7th Nov 20193:54 pmRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSBoard Changes
15th Oct 201912:02 pmRNSPrice Monitoring Extension
9th Oct 20193:54 pmRNSDirector/PDMR Shareholding
3rd Oct 20197:00 amRNSH1 2020 Pre-Close Trading Update
17th Sep 20193:36 pmRNSDirector/PDMR Shareholding
17th Sep 20193:22 pmRNSIssue of Equity
13th Sep 20194:27 pmRNSDirector/PDMR Shareholding
9th Sep 20193:06 pmRNSDirector Declaration
30th Aug 201912:02 pmRNSNotification of transaction by PDMR's PCA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.